J.C. Penney shares spike on encouraging outlook

The company reported a loss in the third quarter, but it says that sales trends will improve later this year.

By MSN Money Partner Nov 20, 2013 2:02PM
Shoppers at a J.C. Penney store in New York, NY on October 23, 2009 (© Mark Lennihan/AP)By Matthew Boesler, Business Insider

Shares of J.C. Penney (JCP) were headed higher in pre-market trading following the release of third-quarter earnings results Wednesday morning.

By midday, shares were up 7.5% to $9.37.

The embattled retailer reported an adjusted loss of $1.81 per share in the third quarter, which may not compare with the consensus estimate for a $1.74 loss per share, as it includes a 73-cent loss per share on tax valuation allowance.


Revenue came in at $2.78 billion, below the consensus $2.80 billion estimate.


Despite a 4.8% drop in same-store sales in the third quarter, the company believes same-store sales trends will improve in the fourth quarter. In October, same-store sales were up 0.9%.


More from Business Insider


Tags: JCP
0Comments

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

RECENT QUOTES

WATCHLIST

Symbol
Last
Change
Shares
Quotes delayed at least 15 min
Sponsored by:

MARKET UPDATE

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] Equity indices have extended to fresh session highs with the Nasdaq pushing its gain to 1.1%. Chipmakers pressured the broader market earlier and remain among the laggards, but the PHLX Semiconductor Index has narrowed its loss to 0.5%.

Elsewhere within the tech-heavy space, biotechnology continues showing relative strength. The iShares Nasdaq Biotechnology ETF (IBB 222.59, +4.98) trades higher by 2.3% after finding support at its 200-day moving average, which is a ... More


Currencies

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.